CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-06 | MURPHY ANDREW J EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +13,472 | 13,472 | ||
| 2024-12-06 | McCourt Marion EVP Commercial | Grant or award | +2,332 | 15,263 | ||
| 2024-12-06 | McCourt Marion EVP Commercial | Grant or award · Non-Qualified Stock Option (right to buy) | +8,981 | 8,981 | ||
| 2024-12-06 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award | +2,332 | 31,269 | ||
| 2024-12-06 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award · Non-Qualified Stock Option (right to buy) | +8,981 | 8,981 | ||
| 2024-12-06 | Pitofsky Jason VP Controller | Grant or award | +907 | 5,111 | ||
| 2024-12-06 | Pitofsky Jason VP Controller | Grant or award · Non-Qualified Stock Option (right to buy) | +3,236 | 3,236 | ||
| 2024-12-06 | Fenimore Christopher R. SVP Finance & CFO | Grant or award | +2,591 | 17,896 | ||
| 2024-12-06 | Fenimore Christopher R. SVP Finance & CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +9,979 | 9,979 | ||
| 2024-12-06 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award | +3,499 | 36,253 | ||
| 2024-12-06 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award · Non-Qualified Stock Option (right to buy) | +13,472 | 13,472 | ||
| 2024-11-08 | MURPHY ANDREW J EVP Research | Gift | −1,185 | 47,121 | ||
| 2024-11-01 | McCourt Marion EVP Commercial | Option exercise 10b5-1 | +1,000 | $381.40 | $381K | 13,931 |
| 2024-11-01 | McCourt Marion EVP Commercial | Sale 10b5-1 | −1,000 | $844.61 | $845K | 12,931 |
| 2024-11-01 | McCourt Marion EVP Commercial | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,000 | 6,000 | ||
| 2024-10-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −3 | $1,041.35 | $3K | 17,679 |
| 2024-10-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $1,042.31 | $1K | 17,678 |
| 2024-10-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −5 | $1,043.39 | $5K | 17,673 |
| 2024-10-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −9 | $1,044.62 | $9K | 17,664 |
| 2024-10-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −7 | $1,045.27 | $7K | 17,657 |
Page 16 of 49 · 971 trades